loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2048264 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DIGOXIN (1)

filter

01 SANDOZ CANADA INCORPORATED (1)

filter

01 LIQUID (1)

filter

01 0.5MG/2ML (1)

filter

01 Canada (1)

URL Supplier Web Content
LIQUID
0.5MG/2ML
DIGOXIN INJECTION C.S....
Canada
2048264
10X2ML
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2048264

Looking for CTD TGA MCC DOSSIER APPLICATION 2048264 1

19

Sandoz B2B, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for A global leader in antibiotics.

One of their notable products is DIGOXIN, with a corresponding application number 2048264 and regulatory information .

proudly manufactured in the

Sandoz B2B's DIGOXIN INJECTION C.S.D. LIQUID, medication with 0.5MG/2ML of DIGOXIN.

Post Enquiry
POST ENQUIRY